B-cell prolymphocytic leukemia epidemiology and demographics
|
B-cell prolymphocytic leukemia |
|
Differentiating B-cell prolymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
B-cell prolymphocytic leukemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia epidemiology and demographics |
|
FDA on B-cell prolymphocytic leukemia epidemiology and demographics |
|
CDC on B-cell prolymphocytic leukemia epidemiology and demographics |
|
B-cell prolymphocytic leukemia epidemiology and demographics in the news |
|
Blogs on B-cell prolymphocytic leukemia epidemiology and demographics |
|
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for B-cell prolymphocytic leukemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2],Carlos A Lopez, M.D. [3]
Overview
The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias. B-cell prolymphocytic leukemia affects males and females equally.
Epidemiology and demographics
Age
- The median age for the development of B-cell prolymphocytic leukemia is around 65-69 years of age.[1][2]
Incidence
- The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias.[3]
Gender
Survival
- The duration of median survival for this disease is 30-50 months.
References
- ↑ "National cancer institute".
- ↑ Melo JV, Catovsky D, Galton DA (June 1986). "The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group". Br. J. Haematol. 63 (2): 377–87. PMID 3487341.
- ↑ 3.0 3.1 Yamamoto JF, Goodman MT (May 2008). "Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002". Cancer Causes Control. 19 (4): 379–90. doi:10.1007/s10552-007-9097-2. PMID 18064533.